Genmab — Januar 2020
-
Dara on the agenda of the EMA Paediatric Committee (PDCO). Only reveals it has to do with Systemic light chain amyloidosis https://www.ema.europa.eu/en/documents/agenda/agenda-pdco-agenda-28-31-january-2020-meeting_en.pdf
-
De får 4 gange så meget plads https://patch.com/illinois/deerfield/horizon-buying-vacant-former-takeda-headquarters-deerfield
-
Det ved vi 17.00..;-)
-
følg med i Corona nyheder her (opdateres løbende) : https://www.cnbc.com/2020/01/30/coronavirus-latest-updates.html
-
"Then there’s Novartis’ cancer drug Arzerra (ofatumumab), which the company has been working to repurpose in MS. Results from clinical trials of the drug have been so impressive that a group of physicians polled by SVB Leerink late last year listed it as one of the most promising choices for treating MS, even though it has not yet been approved for that use." https://www.fiercepharma.com/pharma/biogen-s-tecfidera-holds-its-own-ms-as-competitive-and-generic-threats-loom
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind